Maria A. González-Carmona

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma

Bettina Langhans, Hans Dieter Nischalke, Benjamin Krämer et al. · Cancer Immunology Immunotherapy · 2019 · 150 citations · Full text

Checkpoint Inhibition, Cancer Immunosurveillance, Hepatology +10

Angiotensin-II Type 1 Receptor-Mediated Janus Kinase 2 Activation Induces Liver Fibrosis

M Granzow, Robert Schierwagen, Sabine Klein et al. · Hepatology · 2014 · 124 citations · Full text

High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity

Milka Marinova, Maximilian Rauch, Martin Mücke et al. · European Radiology · 2016 · 81 citations

Medical Ultrasound, Focused Ultrasound, Pancreatic Cancer +9

Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma

Maria A. González-Carmona, Maximilian Bolch, Christian Jansen et al. · Alimentary Pharmacology & Therapeutics · 2019 · 81 citations · Full text